Literature DB >> 2563265

Effects of acute ischemia in the dog on myocardial blood flow, beta receptors, and adenylate cyclase activity with and without chronic beta blockade.

J S Karliner1, M B Stevens, N Honbo, J I Hoffman.   

Abstract

We ligated the left anterior descending coronary artery for 1 or 2 h in 31 purebred beagles. We did not detect any changes in beta-adrenergic receptor density or affinity when normal and ischemic zones were compared, either in the subendocardium or in the subepicardium. In the ischemic zones, there was a significant decline in all measures of adenylate cyclase activity, including activity mediated by the beta-adrenergic receptor. By contrast, after chronic beta-adrenergic blockade (1.5 mg/kg propranolol i.v. twice daily for 7 d), there was an increase in adenylate cyclase activity stimulated by (-)-isoproterenol relative to adenylate cyclase activity stimulated by guanyl-5'imidodiphosphate (GppNHp) in both normal and ischemic tissue, suggesting that one effect of chronic beta blockade may be to enhance coupling between the stimulatory guanine nucleotide regulatory protein (Gs) and the beta-adrenergic receptor, despite a reduction in the number or function of Gs units. Chronic beta blockade also led to up regulation of beta-adrenergic receptor density in subepicardial regions. After 20 min of reperfusion following 2 h of ischemia, adenylate cyclase activity tended to return to control levels, particularly in the subepicardium, where (-)-isoproterenol-stimulated adenylate cyclase activity was not different from normal myocardium. We conclude that chronic beta-adrenergic blockade may have beneficial effects during prolonged episodes of myocardial ischemia by preserving signal transduction mediated by the beta-adrenergic receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563265      PMCID: PMC303703          DOI: 10.1172/JCI113906

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Myocardial ischemic injury and beta-adrenergic receptors in perfused working rabbit hearts.

Authors:  H M Rhee; L Tyler
Journal:  Adv Exp Med Biol       Date:  1985       Impact factor: 2.622

3.  Effects of ischemia on the canine myocardial beta-adrenoceptor-linked adenylate cyclase system.

Authors:  M Freissmuth; W Schütz; M Weindlmayer-Göttel; M Zimpfer; C K Spiss
Journal:  J Cardiovasc Pharmacol       Date:  1987-11       Impact factor: 3.105

4.  A new simple method for separation of adenosine 3',5'-cyclic monophosphate from other nucleotides and its use in the assay of adenyl cyclase.

Authors:  J Ramachandran
Journal:  Anal Biochem       Date:  1971-09       Impact factor: 3.365

5.  Stimulation of 3',5'-cyclic AMP formation in dog myocardium following arrest of blood flow.

Authors:  A Wollenberger; E G Krause; G Heier
Journal:  Biochem Biophys Res Commun       Date:  1969-08-15       Impact factor: 3.575

6.  Early changes in energy metabolism in the myocardium following acute coronary artery occlusion in anesthetized dogs.

Authors:  W Braasch; S Gudbjarnason; P S Puri; K G Ravens; R J Bing
Journal:  Circ Res       Date:  1968-09       Impact factor: 17.367

7.  Beta adrenergic receptor blockade of feline myocardium. Cardiac mechanics, energetics, and beta adrenoceptor regulation.

Authors:  G Cooper; R L Kent; P McGonigle; A M Watanabe
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

8.  Mechanisms and time course of beta 1 adrenoceptor desensitisation in mammalian cardiac myocytes.

Authors:  J S Karliner; P C Simpson; N Honbo; W Woloszyn
Journal:  Cardiovasc Res       Date:  1986-03       Impact factor: 10.787

9.  Beta-adrenergic receptor properties of canine myocardium: effects of chronic myocardial infarction.

Authors:  J S Karliner; M Stevens; M Grattan; W Woloszyn; N Honbo; J I Hoffman
Journal:  J Am Coll Cardiol       Date:  1986-08       Impact factor: 24.094

10.  One hour of myocardial ischemia in conscious dogs increases beta-adrenergic receptors, but decreases adenylate cyclase activity.

Authors:  D E Vatner; D R Knight; Y T Shen; J X Thomas; C J Homcy; S F Vatner
Journal:  J Mol Cell Cardiol       Date:  1988-01       Impact factor: 5.000

View more
  6 in total

1.  Hypoxia and glucose independently regulate the beta-adrenergic receptor-adenylate cyclase system in cardiac myocytes.

Authors:  K J Rocha-Singh; N Y Honbo; J S Karliner
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

2.  Reduced beta-adrenergic receptor activation decreases G-protein expression and beta-adrenergic receptor kinase activity in porcine heart.

Authors:  P Ping; R Gelzer-Bell; D A Roth; D Kiel; P A Insel; H K Hammond
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

3.  Concanavalin A amplifies both beta-adrenergic and muscarinic cholinergic receptor-adenylate cyclase-linked pathways in cardiac myocytes.

Authors:  K J Rocha-Singh; D K Hines; N Y Honbo; J S Karliner
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

4.  Regional myocardial downregulation of the inhibitory guanosine triphosphate-binding protein (Gi alpha 2) and beta-adrenergic receptors in a porcine model of chronic episodic myocardial ischemia.

Authors:  H K Hammond; D A Roth; M D McKirnan; P Ping
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

5.  Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.

Authors:  M R Bristow; W Minobe; R Rasmussen; P Larrabee; L Skerl; J W Klein; F L Anderson; J Murray; L Mestroni; S V Karwande
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

6.  Complex regulation of calcium current in cardiac cells. Dependence on a pertussis toxin-sensitive substrate, adenosine triphosphate, and an alpha 1-adrenoceptor.

Authors:  E C Keung; J S Karliner
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.